REGN2810 (Anti-PD-1 Antibody), Platinum-based Doublet Chemotherapy, and Ipilimumab (Anti-CTLA-4 Antibody) Versus Pembrolizumab Monotherapy in Patients With Lung Cancer
- Status
- TERMINATED
- Phase
- PHASE3
Clinical Trials Related to Regeneron Pharmaceuticals
Related studies linked through entity extraction aliases.
An Efficacy and Safety Study of Alirocumab in Children and Adolescents With Heterozygous Familial Hypercholesterolemia
- Status
- COMPLETED
- Phase
- PHASE3
An Efficacy and Safety Study of Alirocumab in Children and Adolescents With Homozygous Familial Hypercholesterolemia
- Status
- COMPLETED
- Phase
- PHASE3
PCSK9 Inhibition in Patients With Symptomatic Intracranial Atherosclerosis
- Status
- TERMINATED
- Phase
- EARLY_PHASE1
Expanded Access Protocol for Cemiplimab in Metastatic or Locally Advanced Cutaneous Squamous Cell Carcinoma
- Status
- NO_LONGER_AVAILABLE
- Phase
- N/A
To Assess the Patients' Ability to Self-Administer Fasinumab
- Status
- COMPLETED
- Phase
- PHASE1
Alirocumab in Patients on a Stable Dialysis Regimen
- Status
- UNKNOWN
- Phase
- PHASE3
Stereotactic Body Radiation Therapy With REGN2810 and/or Ipilimumab Before Surgery in Treating Participants With Progressive Advanced or Oligometastatic Prostate Cancer
- Status
- WITHDRAWN
- Phase
- PHASE1
Two-week Retreatment Interval Study for Treated Age-related Macular Degeneration Refractory to Monthly Aflibercept
- Status
- UNKNOWN
- Phase
- PHASE4
Safety and Efficacy Following Repeat-Dose of Evinacumab (Anti-ANGPTL3) in Patients With Severe Hypertriglyceridemia (sHTG) at Risk for Acute Pancreatitis
- Status
- COMPLETED
- Phase
- PHASE2
Effect of Sarilumab on Patient-reported Outcomes in Patients With Active Rheumatoid Arthritis
- Status
- COMPLETED
- Phase
- PHASE4
Study Evaluating CMP-001 in Combination With Atezolizumab in Participants With Non-Small Cell Lung Cancer
- Status
- COMPLETED
- Phase
- PHASE1
A Study of REGN2810 and Ipilimumab in Patients With Lung Cancer
- Status
- TERMINATED
- Phase
- PHASE2
Study of Patients Receiving DUPIXENT® for Atopic Dermatitis (AD)
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- N/A
Usability Study of the Commercial Auto-injector Device and the New Auto-injector Device (SYDNEY) in Patients With High or Very High CV Risk With Hypercholesterolemia Not Adequately Controlled With Their Lipid-Modifying Therapy
- Status
- COMPLETED
- Phase
- PHASE3
Evaluate the Effectiveness of Intravitreal (IVT) Aflibercept Injection in Clinical Practice in naïve Patients With Neovascular Age-related Macular Degeneration (nAMD)
- Status
- COMPLETED
- Phase
- N/A
Evaluate the Long-Term Safety and Efficacy of Evinacumab in Patients With Homozygous Familial Hypercholesterolemia
- Status
- COMPLETED
- Phase
- PHASE3
Combinations of Cemiplimab (Anti-PD-1 Antibody) and Platinum-based Doublet Chemotherapy in Patients With Lung Cancer
- Status
- COMPLETED
- Phase
- PHASE3
Efficacy and Safety of Evinacumab in Patients With Homozygous Familial Hypercholesterolemia
- Status
- COMPLETED
- Phase
- PHASE3
Treatment of Macular Edema After Cataract Surgery with Subconjunctival Aflibercept
- Status
- TERMINATED
- Phase
- PHASE1